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Abstract
This study addressed the effects of changes in trabecular microarchitecture induced by suppressed
bone turnover — including changes to the remodeling space — on the trabecular bone strength-
volume fraction characteristics independent of changes in tissue material properties. Twenty female
beagle dogs, aged 1–2 years, were treated daily with either oral saline (n=10 control) or high doses
of oral risedronate (0.5 mg/kg/day, n=10 suppressed) for a period of one year, the latter designed
(and confirmed) to substantially suppress bone turnover. High-resolution micro-CT based finite
element models (18-micron voxel size) of canine trabecular bone cores (n=2 per vertebral body)
extracted from the T-10 vertebrae were analyzed in both compressive and torsional loading cases.
The same tissue-level material properties were used in all models, thus providing measures of tissue-
normalized strength due only to changes in the microarchitecture. Suppressed bone turnover resulted
in more plate-like architecture with a thicker and more dense trabecular structure, but the relationship
between the microarchitectural parameters and volume fraction was unaltered (p>0.05). Though the
suppressed group had greater tissue-normalized strength as compared to the control group (p<0.001)
for both compressive and torsional loading, the relationship between tissue-normalized strength and
volume fraction was not significantly altered for compression (p>0.13) or torsion (p>0.09). In this
high-density, non-osteoporotic animal model, the increases in tissue-normalized strength seen with
suppression of bone turnover were entirely commensurate with increases in bone volume fraction
and thus, no evidence of microarchitecture-related or “stress-riser” effects which may
disproportionately affect strength were found.
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INTRODUCTION
It has been hypothesized that geometric changes to the remodeling space through bone turnover
suppression-induced inhibition of trabecular perforation (Riggs and Melton, 2002), changes in
microarchitecture and filling in of resorption cavities (Parfitt, 2002) may together reduce
theorized “stress-riser” effects associated with remodeling cavities, thus strengthening the
bone. Biomechanically, the effects of any such changes in trabecular bone quality can be
quantified by analysis of the relationship between measures of biomechanical performance —
such as strength — and bone density or bone volume fraction (Hernandez and Keaveny,
2006). However, because suppression of bone turnover results in simultaneous changes to the
trabecular microarchitecture, mineralization, and/or collagen cross-linking (Boivin et al.,
2000; Borah et al., 2004; Ding et al., 2003; Burr et al., 2003), it is difficult to quantify the
independent effects on strength due only to microarchitectural changes. Understanding the
contribution of suppression-induced changes in trabecular bone volume fraction and
microarchitecture towards increased bone strength independent of tissue material properties
may lead to improved means of evaluating treatment efficacy by providing insight into the
biomechanical mechanisms by which antiresorptive treatments substantially reduce clinical
fracture risk (Cummings et al., 2002; Delmas, 2000).
While the effects of suppressed bone turnover on the mineralization and the organic component
of the trabecular tissue, and trabecular microarchitecture have been investigated through a
number of clinical (Boivin et al., 2000; Borah et al., 2004; Borah et al., 2005; Roschger et al.,
2001) and pre-clinical studies (Allen et al., 2006a; Allen et al., 2006b; Day et al., 2004; Ding
et al., 2003; Ito et al., 2005; Mashiba et al., 2001; Muller et al., 2004), the independent
contribution of suppression-induced microarchitectural changes alone to the improved
mechanical properties remain unclear. Analysis of simulated microarchitectural changes have
shown that inhibition of trabecular perforation (Guo and Kim, 2002; Riggs and Melton,
2002) and filling in of the remodeling space (Hernandez et al., 2006; Parfitt, 2002) may have
a disproportionate effect on trabecular bone strength compared to the accompanying changes
in bone volume fraction, particularly for low-density bone. It is also possible that the
biomechanical effects of suppression-induced architectural changes may be sensitive to the
loading mode, e.g. compression vs. torsion, since there is evidence that the failure mechanisms
in trabecular bone depend on the loading mode (Niebur et al., 2002). Predominantly torsional
loading, which can occur during non-habitual activities, would result in increased bending of
trabeculae (Fenech and Keaveny, 1999), an effect that may accentuate strength changes due
to alterations in microarchitecture and the remodeling space.
Our overall goal was to investigate the independent contribution of bone turnover suppression-
induced changes to trabecular bone volume fraction and microarchitecture on bone strength
by eliminating any changes to the tissue material properties. Given the dearth of large-animal
models with trabecular bone volume fraction comparable to that of elderly human vertebral
bone (Table 1), we analyzed trabecular bone cores taken from canine vertebrae from an ongoing
animal experiment using high-resolution finite element modeling to gain early insight into this
issue. Specifically, our objectives were to determine the effect of suppression of bone turnover
by high-dose risedronate treatment on: 1) the trabecular microarchitecture-volume fraction
relationships; and 2) the strength-volume fraction characteristics for both compressive and
torsional loading. This study is unique in its focus on the mechanical consequences of
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suppression-induced microarchitectural changes and its use of fully nonlinear micro-CT based
finite element models for strength predictions in two different loading modes.
METHODS
Details of the experimental design have been published previously (Allen et al., 2006a).
Twenty-four female beagle dogs, aged 1–2 years, were randomly assigned to two weight-
matched groups — control and suppressed (turnover). Because some bone had been used for
preliminary studies, only twenty of the dogs were available for the current study. X-rays
obtained prior to the start of the study confirmed that the vertebral growth plates were closed.
The control group (n=10 animals) was given oral saline and the suppressed group (n=10
animals) was given oral risedronate (0.5 mg/kg/day) daily for a period of one year and both
groups were then sacrificed. This dosage of risedronate is five-fold higher than the clinical
dose used to treat post-menopausal osteoporosis, is equivalent to the dose used to treat Paget’s
disease, and, was chosen to ensure maximal suppression of bone turnover. Previously published
data obtained from the second lumbar vertebrae of these same dogs showed that the activation
frequency was 84% lower (p<0.0001) in the suppressed bone compared to the control bone
(Allen et al., 2006a), confirming that the treatment substantially suppressed bone turnover.
The T-10 vertebral bodies obtained from the harvested dogs were scanned with micro-CT at
18 μm voxel size (Scanco 80, Basserdorf, Switzerland). An automated adaptive threshold
algorithm (provided as part of the scanner) was used to select a global specimen-specific
threshold to segment bone from any surrounding material. Two cylindrical cores (diameter =
3.5 mm, height = 6 mm nominal dimensions) were virtually removed from each scan such that
the basivertebral foramen and the cortex were avoided (Figure 1). To satisfy the continuum
assumption for analysis of trabecular bone, the minimum dimension is recommended to be
greater than five trabecular spacings (Harrigan et al., 1988). For example, in human vertebral
bone, the mean trabecular spacing is approximately 0.8 mm (Ulrich et al., 1999), so a 4 mm
dimension is required to satisfy the continuum assumption. Since the mean trabecular spacing
of canine bone is only about 0.4 mm (Ding et al., 2003), the continuum assumption requires a
minimum specimen size of 2 mm. Visual inspection of the canine vs. human specimens
confirms these calculations (Figure 2). The microarchitectural properties of the trabecular bone
cores were determined from the segmented 3-D image data (Scanco; Scanco Medical AG,
Basserdorf, Switzerland). Trabecular bone volume fraction (BV/TV), structural model index
(SMI), connectivity density (CD), degree of anisotropy (DA), bone surface density (BS/BV),
mean and SD of trabecular thickness (Tb. Th.), trabecular spacing (Tb. Sp.) and trabecular
number (Tb. N) were calculated (Hildebrand et al., 1999).
To ensure that any observed changes in predicted strength were due only to changes in
microarchitecture, the same tissue-level elastic and yield properties — a Young’s modulus of
18.5 GPa, Poisson’s ratio of 0.3, and tensile and compressive yield strains of 0.33% and 0.81%,
respectively (Bevill et al., 2006) — were assigned to all specimens in both the control and
suppressed groups. Using custom code with a parallel mesh partitioner and multigrid solver
(Adams et al., 2004), two fully nonlinear finite element analyses — including material and
geometric non-linearities (Bevill et al., 2006) — were performed on each model (n=80 total)
using both compressive and torsional apparent loading. Each model had approximately 4
million degrees of freedom and analyses were run on an IBM-SP4 supercomputer (Datastar,
San Diego) using 24 processors, requiring a total of approximately 12,000 CPU hours. This
analysis technique has been previously validated for human trabecular bone (Bevill et al.,
2006).
From the finite element analyses, apparent level strength (0.2% offset yield stress) was
calculated for compression and torsional loading (Ford and Keaveny, 1996; Nádai, 1950).
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Since the predicted strength was independent of changes in the tissue material properties, this
strength measure will be referred to as tissue-normalized strength. As expected, we found that
the tissue-normalized strength was linearly correlated with bone volume fraction and this linear
relation had a non-zero intercept. As a result, the slope of the relationship between tissue-
normalized strength and volume fraction was different from the ratio of tissue-normalized
strength to volume fraction (Hernandez and Keaveny, 2006). The ratio of tissue-normalized
strength to volume fraction represents a measure of the structural efficiency of the bone
(Hernandez and Keaveny, 2006), since for a given volume fraction, bone having a higher ratio
of tissue-normalized strength to volume fraction will have higher strength. Thus, the strength-
volume fraction characteristics were quantified by both the linear relationship between tissue-
normalized strength and volume fraction, and the ratio of tissue-normalized strength to volume
fraction.
Statistical analyses were performed to test for effects of suppressed bone turnover on the
trabecular microarchitecture and tissue-normalized strength. A restricted maximum likelihood
(REML) test was used in order to account for the replicate samples (n=2) taken from each
specimen by including the specimen ID as a random effect (JMP, Version 5.0, SAS Institute
Inc., Cary, NC). The treatment group and the specimen ID were the explanatory variables in
the statistical comparison of the mean values of the microarchitectural parameters, tissue-
normalized strength and the ratio of tissue-normalized strength to volume fraction between the
control and suppressed groups. The microarchitecture- and tissue-normalized strength-volume
fraction relationships (slope and intercept) of the control and suppressed groups were compared
using the REML test with bone volume fraction, treatment group (corresponds to a change in
the intercept), specimen ID and cross product between bone volume fraction and treatment
group (corresponds to a change in the slope) as explanatory variables. The lower p-value among
those for slope and intercept differences is reported. All statistical analyses were done
separately for compression and torsion loading cases.
RESULTS
Suppression of bone turnover was associated with a more plate-like architecture having thicker
and more dense trabecular structure. These changes were consistent with what would be
expected in normal (control) bone of a higher volume fraction since the relationship between
the microarchitectural parameters and volume fraction was not significantly different (p>0.05)
between the control and suppressed groups (Table 2).
As with microarchitecture, changes in tissue-normalized strength seen with suppressed bone
turnover were consistent with those expected with natural variations in bone volume fraction.
The (linear) relationship between tissue-normalized strength and volume fraction (both slope
and intercept) was not statistically different between the control and suppressed groups (Figure
3) for either compression (p>0.13) or torsion (p>0.09) load cases even though tissue-
normalized strength increased much more on a percentage basis than did volume fraction
(Table 3).
As a result of the natural dependence of the ratio of tissue-normalized strength to volume
fraction (Figure 4), the mean value of this ratio for the suppressed group was significantly
higher than that of the control group for both compression and torsion load cases (Table 3).
The ratio of tissue-normalized strength to volume fraction depended (p<0.05) on volume
fraction for both the control and suppressed groups, and for both loading modes.
Eswaran et al. Page 4
J Biomech. Author manuscript; available in PMC 2008 January 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
DISCUSSION
The goal of this study was to investigate how changes in the canine trabecular bone volume
fraction and microarchitecture induced by suppression of bone turnover affected the strength
of trabecular bone independent of alterations in tissue material properties. The models, by
design, eliminated any possible changes in hard tissue properties from affecting these
comparisons, thus providing measures of tissue-normalized strength. We found no evidence
of any increases in tissue-normalized strength with suppression of bone turnover that were not
commensurate with the increases in bone volume fraction, and no evidence of any stress-riser
effects. Thus, while there may be subtle differences between the control and suppressed bone
in terms of microarchitecture, suppression of bone turnover did not fundamentally alter the
trabecular microarchitecture- or tissue-normalized strength-volume fraction relations. As the
bone increases in volume fraction, the ratio of tissue-normalized strength to volume fraction
increases naturally. As a result, the higher mean ratio of tissue-normalized strength to volume
fraction observed for the suppressed group was a direct consequence of the natural dependence
of this ratio on bone volume fraction. Taken together, these results indicate that there were no
appreciable microarchitecure-related bone quality effects — as defined in the context of this
study — associated with suppression of bone turnover in this animal model.
A major feature of this analysis is that we quantified the biomechanical effects due only to
changes in the trabecular microarchitecture, a technique that can also be applied to small-animal
models provided the minimum dimension of the trabecular specimen satisfies the continuum
assumption (Harrigan et al., 1988). We extended the technique utilized by Day et al. (Day et
al., 2004) to isolate the effects of suppression-induced microarchitectural changes from any
alterations in tissue material properties. The latter issue — including the effect of suppressed
bone turnover on the mineralization and organic component of the trabecular tissue (Boivin et
al., 2000; Burr et al., 2003; Roschger et al., 2001) — was not addressed in this analysis and it
is possible that interactions between microarchitecture and tissue material properties could
exist. Another notable feature was our use of two loading modes — compression and torsion
— to test whether the effects of suppressed bone turnover depended on the choice of the loading
mode. We had hypothesized that the biomechanical effects associated with the filling of
remodeling cavities (Storm et al., 1993) might be accentuated for torsional loading, but no such
effects were detected. A third important feature was our use of fully-nonlinear finite element
analysis — previously validated for human trabecular cores (Bevill et al., 2006) — for our
strength predictions.
One notable caveat of this study was the use of a non-osteoporotic, high-bone volume fraction
animal model. Due to their low baseline estrogen levels, these dogs do not lose substantial
trabecular bone with ovariectomy (Shen et al., 1992) and thus were not ovariectomized. There
could be inherent differences in the physiological responses of canine and human bone. The
high bone volume fraction and associated plate-type architecture in this model could affect the
degree of response. For example, because of the relatively high bone volume fraction (0.20 ±
0.03) of the control specimens as compared to human vertebral bone (Figure 5), certain failure
mechanisms such as large deformation bending (Bevill et al., 2006) or buckling (Gibson,
1985; Stolken and Kinney, 2003) may not be manifested in such a model (Bevill et al.,
2006). Comparison of the trabecular microarchitectural parameters of different large-animal
models shows a complete lack of large-animal models with trabecular bone volume fraction
or trabecular spacing comparable to that of elderly human vertebral bone (Table 1). Care should
be taken therefore, in extrapolating these results, or those from any current large-animal
models, to elderly humans. For eventual clinical applications concerning the role of treatment-
induced microarchitectural changes, one critical challenge will be to develop large-animal
models having bone volume fraction and microarchitecture characteristics more akin to elderly
human trabecular bone.
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One numerical technical issue was the possibly limited spatial resolution of the finite element
models as compared to the physical scale of the remodeling cavities. Since the reduction in
resorption depth reported in humans with antiresorptive treatment is on the order of 10 microns
(Storm et al., 1993), use of finite element models with a voxel size of 18 microns may have
obscured the detection of real effects. Use of linear 8-noded elements might also obscure the
modeling of large stress gradients over the scale of a few elements. Despite these limitations,
evidence from a nonlinear analysis that we performed of a single individual trabecula having
a resorption cavity showed that both the stress distribution as well as the overall strength
predicted by a 20-micron model compared well with the outcomes of a 2-micron model (Figure
6). Moreover, strength predictions from finite element models of human vertebral trabecular
bone cores (with voxel size of 20-micron) were well-correlated with experimental strength
measurements (Bevill et al., 2006). These results suggest that the voxel size of 18 microns was
sufficient to capture any differences in finite element-predicted strength between the control
and suppressed groups in this study.
Our results are largely consistent with previous studies on similar canine models (Day et al.,
2004; Ding et al., 2003). Though the specific values of architectural parameters and their
change with suppressed bone turnover differ, the overall trends in these parameters were
consistent with those reported by Ding et al. (Ding et al., 2003) except for connectivity density.
Previous studies have reported that plate perforations without loss of trabecular elements tend
to artificially increase connectivity (Borah et al., 2004), and this may explain why the
connectivity density for the control bone tended to be higher than the suppressed bone in this
study. The trends in architectural changes due to suppressed bone turnover are also consistent
with previous clinical (Borah et al., 2004) and pre-clinical (Ito et al., 2005; Muller et al.,
2004) studies which have shown that antiresorptive treatment preserves the trabecular
architecture.
Previous animal studies have seldom compared the strength-density relationship of control and
turnover-suppressed bone. The correlation coefficient of the strength-volume fraction relation
reported in this study for the control group was comparable to that reported in previous animal
studies (Ito et al., 2005; Muller et al., 2004) for the control group, but differs from that of
various OVX (ovariectomy) groups. For example, a computational study on rat tibiae reported
that the trabecular bone strength-volume fraction relation (Ito et al., 2005) was not statistically
significant for the OVX-control group. However, those analyses involved trabecular specimens
(OVX-control group) that were not large enough to satisfy the continuum assumption (Harrigan
et al., 1988). Another study involving ovariectomy reported that the R2 value between whole-
vertebral strength and bone mineral content was much lower for the OVX-control group as
compared to the sham-control group (Muller et al., 2004). This is consistent with other studies
that have observed an increase in whole-vertebral strength per unit areal BMD (measured by
DXA) after treatment with SERM (selective estrogen receptor modulator) raloxifene but not
with the antiresorptives (Allen et al., 2006b). The changes associated with estrogen deficiency
or treatments on whole-vertebral strength may be a result of treatment effects on tissue-level
material properties, or could be due to higher scale effects such as differential treatment effects
on cortical vs. trabecular bone or periosteal remodeling (Allen et al., 2004; Delmas, 2000). In
summary, although alterations in the remodeling space may have a disproportionate effect on
strength in elderly human bone, particularly if the remodeling cavities occur predominantly in
regions of high tissue-level stress (Hernandez et al., 2006), we found no such microarchitecture-
related effects in this high-density canine model.
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Figure 1.
Mid-transverse slice from a canine vertebral body (scanned at 18-micron voxel size) shows
the location of the cylindrical trabecular bone cores obtained such that the basivertebral
foramen and the cortical shell were avoided.
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Figure 2.
Transverse and vertical slices of cylindrical cores from (A) human vertebral body, (B) human
femoral neck and (C) canine vertebral body showing that the canine cylindrical cores satisfies
the continuum assumption. The specimen diameters for the human vertebral body (d=8 mm),
human femoral neck (d=8 mm) and canine vertebral body (d=3.5 mm) were scaled to the same
size for visual comparison.
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Figure 3.
Suppression-induced architectural changes did not significantly alter the relationship between
tissue-normalized strength and volume fraction for either compression (p>0.13) or torsion
(p>0.09) load cases.
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Figure 4.
Variation of tissue-normalized strength:volume fraction ratio with volume fraction for the
compression (Left) and torsion (Right) load cases.
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Figure 5.
Comparison of finite element predicted strength-volume fraction characteristics of human and
canine trabecular bone indicating that canine control bone volume fraction was comparable to
that of human femoral neck bone. Previously published data on human trabecular bone is
presented here (Bevill et al., 2006).
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Figure 6.
Left: “Nano-CT” 3D scan of an individual trabecula (480 nm resolution) obtained from a
human vertebral body showing the presence of a resorption cavity (arrow). Right: Force-
displacement curves at 2-μm and 20-μm for compressive loading of the individual trabecula
showing that the coarse model with a 20-μm voxel size accurately captures the strength
behavior predicted by the 2-μm model.
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Table 1
Comparison of architectural parameters between various animal models and human trabecular bone obtained
from vertebral bodies (Mean ± SD).
Sample Size BV/TV Tb.Sp. (mm) Tb. Th. (mm)
Canine (Ding et al., 2003) 11 0.22 ± 0.03 0.41 ± 0.06 0.099 ± 0.011
OVX Monkey (Muller et al.,
2004)
13 0.26 ± 0.05 0.32 ± 0.06 0.111 ± 0.015
Sheep (Lill et al., 2002) 16 0.27 ± 0.09 0.37 ± 0.06 0.11 ± 0.04
Human (Ulrich et al., 1999) 58 0.08 ± 0.02 0.80 ± 0.13 0.123 ± 0.016
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Table 3
Comparison of the finite element-predicted mechanical properties and bone volume fraction between the control
and turnover-suppressed groups (Mean ± SD, n=20 in each group).
Control Suppressed % Difference† p-value*
Volume fraction, BV/TV 0.20 ± 0.03 0.24 ± 0.01 23.9 <0.0001
Compression:
 Tissue-normalized strength [MPa] 8.4 ± 2.1 11.5 ± 1.6 37.7 0.0009
 Tissue-normalized strength/(BV/
TV) [MPa]
42.4 ± 5.9 47.6 ± 5.0 9.7 0.04
Torsion:
 Tissue-normalized strength [MPa] 3.1 ± 0.9 4.6 ± 0.6 46.0 0.0004
 Tissue-normalized strength/(BV/
TV) [MPa]
15.7 ± 2.8 18.9 ± 1.7 20.0 0.0054
*
p<0.05 indicates statistically significant difference in the mean values of the control and suppressed groups after accounting for replicate samples from
each vertebral body.
†
Percent difference calculated with respect to the control means.
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